LivaNova (LIVN) Gross Margin (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 85.00 |
| Dec 31, 2025 | -201.00 |
| Sep 30, 2025 | 65.00 |
| Jun 30, 2025 | -46.00 |
| Mar 31, 2025 | 164.00 |
| Dec 31, 2024 | -287.00 |
| Sep 30, 2024 | 203.00 |
| Jun 30, 2024 | -145.00 |
| Mar 31, 2024 | 1,256.00 |
| Dec 31, 2023 | -1,419.00 |
| Sep 30, 2023 | 71.00 |
| Jun 30, 2023 | 374.00 |
| Mar 31, 2023 | -68.00 |
| Dec 31, 2022 | -90.00 |
| Sep 30, 2022 | -487.00 |
| Jun 30, 2022 | 240.00 |
| Mar 31, 2022 | -453.00 |
| Dec 31, 2021 | 806.00 |
| Sep 30, 2021 | 147.00 |
| Jun 30, 2021 | -86.00 |
| Mar 31, 2021 | 408.00 |
| Dec 31, 2020 | 44.00 |
| Sep 30, 2020 | -162.00 |
| Jun 30, 2020 | -510.00 |
| Mar 31, 2020 | 820.00 |
| Dec 31, 2019 | -794.00 |
| Sep 30, 2019 | -503.00 |
| Jun 30, 2019 | 656.00 |
| Mar 31, 2019 | -314.00 |
| Dec 31, 2018 | 547.00 |
| Sep 30, 2018 | -339.00 |
| Jun 30, 2018 | 273.00 |
| Mar 31, 2018 | 291.00 |
| Dec 31, 2017 | -260.00 |
| Sep 30, 2017 | -206.00 |
| Jun 30, 2017 | 139.00 |
| Mar 31, 2017 | 1,485.00 |
| Dec 31, 2016 | -1,429.00 |
| Sep 30, 2016 | 550.00 |
| Jun 30, 2016 | 54.00 |
| Oct 18, 2015 | -248.00 |
| Jul 24, 2015 | -139.00 |